Table 2. Tumour characteristics (n=64).
Numbera | Valid % | |
---|---|---|
Other histological component | ||
Adenocarcinoma | 13 | 21.0 |
Squamous cell carcinoma | 9 | 14.5 |
Anaplastic carcinoma | 1 | 1.6 |
Pure SmCC | 39 | 62.9 |
T stage | ||
I | 5 | 9.8 |
II | 9 | 17.7 |
III | 25 | 49.0 |
IV | 12 | 23.5 |
N status | ||
N+ | 34 | 66.7 |
N0 | 17 | 33.3 |
M status | ||
M1 | 35 | 55.6 |
M0 | 28 | 44.4 |
Sites of metastases at presentationb | ||
Liver | 22 | 37.3 |
Lung | 6 | 10.5 |
Adrenal | 1 | 1.8 |
Peritoneum | 9 | 15.2 |
Soft tissue | 7 | 12.3 |
Bone | 6 | 10.3 |
Brain | 1 | 1.8 |
Number of metastatic sites | ||
0 | 28 | 44.4 |
1 | 11 | 17.5 |
2 | 13 | 20.6 |
⩾3 | 11 | 17.5 |
TNM stagec | ||
I | 4 | 6.8 |
II | 9 | 15.2 |
III | 11 | 18.6 |
IV | 35 | 59.3 |
Extent | ||
Limited | 33 | 52.4 |
Extensive | 30 | 47.6 |
SmCC=small-cell carcinoma. |
Data were missing with regard to other histological component (2 patients), T stage (13), N status (13), M status (1), number of metastatic sites (1), TNM stage (5) and extent of disease (1).
Involvement of the following sites was not specified: liver (5 patients), lung (7), adrenal (8), peritoneum (5), soft tissue (7), bone (6) and brain (8).
According to the 2002 AJCC staging system.